Lexicon Pharmaceuticals | LXRX - Рыночная капитализация

Биржевая цена
1.86
Изменение за день
0.11 6.29%
Ежемесячно
15.53%
Ежегодный
272.00%
Q2 прогноз
1.67




Рыночная капитализация Изменить Дата
Abbott USD 217.86B 15.25B 2025-12
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Illumina USD 20.62B 6.53B 2025-12
Insmed USD 37.12B 6.68B 2025-12
J&J USD 578.59B 562M 2026-04
Lexicon Pharmaceuticals USD 418M 73M 2025-12
MacroGenics USD 102M 4M 2025-12
MannKind USD 1.74B 93M 2025-12
Merck USD 261.26B 51.62B 2025-12
Novartis USD 292.21B 26.55B 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12